fresolimumab
Showing 1 - 7 of 7
Osteogenesis Imperfecta Trial in Portland, Houston (Fresolimumab)
Completed
- Osteogenesis Imperfecta
- Fresolimumab
-
Portland, Oregon
- +1 more
Jul 5, 2022
Stage IA Non-Small Cell Lung Carcinoma, Stage IB Non-Small Cell Lung Carcinoma Trial in Palo Alto (biological, other, radiation)
Completed
- Stage IA Non-Small Cell Lung Carcinoma
- Stage IB Non-Small Cell Lung Carcinoma
- Fresolimumab
- +2 more
-
Palo Alto, CaliforniaStanford University, School of Medicine
Feb 2, 2022
Metastatic Breast Cancer Trial in Los Angeles, New York (Fresolimumab, Radiation Therapy)
Completed
- Metastatic Breast Cancer
- Fresolimumab
- Radiation Therapy
-
Los Angeles, California
- +1 more
Feb 21, 2019
Idiopathic Pulmonary Fibrosis Trial in San Francisco, Boston, New York (EGCG 300 mg + Nintedanib, EGCG 300 mg + Pirfenidone,
Not yet recruiting
- Idiopathic Pulmonary Fibrosis
- EGCG + Nintedanib
- +2 more
-
San Francisco, CaliforniaUCSF Parnassus
Apr 25, 2022
Primary Focal Segmental Glomerulosclerosis Trial in Worldwide (fresolimumab, Placebo)
Completed
- Primary Focal Segmental Glomerulosclerosis
- fresolimumab
- Placebo
-
Birmingham, Alabama
- +31 more
Aug 12, 2015
Diffuse Systemic Sclerosis Trial in Boston (Fresolimumab)
Completed
- Diffuse Systemic Sclerosis
- Fresolimumab
-
Boston, MassachusettsBoston University School of Medicine; Rheumatology/Arthritis Cen
Jul 15, 2014
Primary Brain Tumors Trial in Groningen (89Zr-GC1008, GC1008)
Completed
- Primary Brain Tumors
- 89Zr-GC1008
- GC1008
-
Groningen, NetherlandsUniversity Medical Center Groningen
Nov 13, 2012